Activist investor Elliott Investment Management has acquired a stake in BP (NYSE:BP), aiming to enhance shareholder value. While the exact size of the stake remains undisclosed, Bloomberg reports it is "significant."
Elliott, known for its influence in corporate shakeups, sees BP as undervalued compared to its rivals. The British oil giant, with a market capitalization of $85.62 billion, is worth less than half of Shell (LON:SHEL), which stands at approximately $161 billion.
BP CEO Murray Auchincloss has been focusing on cost-cutting and strategic shifts to regain investor confidence. The company plans to reduce expenses by at least $2 billion by 2026 and recently announced the sale of a German refining site. Additionally, BP will cut over 5% of its global workforce. Auchincloss, who took over in 2023 following Bernard Looney’s abrupt departure, is set to outline his strategic vision at an investor event on February 26.
BP has warned that declining refining margins and maintenance costs could lower quarterly profits by up to $300 million. Other global refiners have also signaled weak near-term profitability due to margin downturns. The company will release its Q4 and full-year earnings on February 11.
Elliott, managing $70 billion in assets, has a history of pushing for major corporate transformations. It recently advocated for a breakup of Honeywell (NASDAQ:HON) and took a 3.2% stake in Anglo American (JO:AGLJ), following BHP Group’s takeover interest.
Neither Elliott nor BP has commented on the investment. However, with BP’s ongoing restructuring and Elliott’s track record in driving change, the oil major may soon face significant strategic shifts.


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Jefferies Lowers Ratings on Three Leading UK Industrial Stocks
Why your retirement fund might soon include cryptocurrency
SoftBank Eyes Up to $25B OpenAI Investment Amid AI Boom
Investors value green labels — but not always for the right reasons
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
China’s Growth Faces Structural Challenges Amid Doubts Over Data
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
S&P 500 Surges Ahead of Trump Inauguration as Markets Rally
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
UK Markets Face Rising Volatility as Hedge Funds Target Pound and Gilts
Tempus AI Stock Soars 18% After Pelosi's Investment Disclosure
Ferrari Group to Launch IPO in Amsterdam, Targets Over $1 Billion Valuation 



